Page 1 of Clinical Trials for unresectable extrahepatic bile duct cancer, 77 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Withdrawn
Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery
Last Updated: December 4, 2006
Condition(s): Cholangiocarcinoma of the Extrahepatic Bile Duct; Cholangiocarcinoma of the Gallbladder; Unresectable Extrahepatic Bile Duct Cancer; Unresectable Gallbladder Cancer; Recurrent Extrahepatic Bile Duct Cancer; Recurrent Gallbladder Cancer
2
Completed
Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder
Last Updated: June 29, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
3
Completed
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Last Updated: October 16, 2009
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
4
Active, not recruiting
S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma
Last Updated: July 13, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer
5
Completed
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer
Last Updated: May 4, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
6
Active, not recruiting
3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Biliary Duct or Gallbladder Cancer
Last Updated: July 23, 2008
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer
7
Active, not recruiting
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
Last Updated: May 19, 2012
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer
8
Completed
Bevacizumab and Erlotinib in Treating Patients With Metastatic or Unresectable Biliary Tumors
Last Updated: September 2, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer
9
Completed
Lapatinib in Treating Patients With Unresectable Liver or Biliary Tract Cancer
Last Updated: April 9, 2010
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
10
Completed
Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Biliary Cancer
Last Updated: January 18, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
11
Recruiting
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors
Last Updated: March 18, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer
12
Completed
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer
Last Updated: March 5, 2012
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Pancreatic Cancer
13
Active, not recruiting
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
Last Updated: March 31, 2009
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Liver Cancer; Unspecified Adult Solid Tumor, Protocol Specific
14
Completed
Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Last Updated: April 18, 2009
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
15
Completed
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor
Last Updated: March 7, 2012
Condition(s): Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gastric Cancer; Head and Neck Cancer; Liver Cancer; Unspecified Adult Solid Tumor, Protocol Specific
16
Active, not recruiting
S0202 Gemcit. and Capecit. for Pts w/Unresect Locally Adv Met Gallbladder Cancer or Cholangiocarcinoma
Last Updated: July 13, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer
17
Active, not recruiting
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
Last Updated: February 6, 2009
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
18
Completed
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas
Last Updated: December 3, 2009
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer; Pancreatic Cancer
19
Recruiting
Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
Last Updated: May 24, 2012
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer
20
Completed
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer
Last Updated: March 12, 2011
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=unresectable+extrahepatic+bile+duct+cancer

Page 1 of Clinical Trials for unresectable extrahepatic bile duct cancer, 77 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About